SciMatic
Journals
Thesis Rep
Docs
Products
SciMatic.net
Journament
Journal Manager
Subjects
Thesis
ImProofer
Research Groups
Letter Pad
Conferences
Services
About
SciMatic
Team
Earn With Us
Join Us
Contact Us
EN
English
Türkçe
Español
Português
Pусский
Filipino
Tiếng Việt
हिन्दी
العربية
বাংলা
Deutsch
中文
Login
Keyword Connections
anti-bacterial agents / therapeutic use
Journals
0
No Journal Connected
Research Groups
0
No Research Group Connected
Bibliographies
87
1
Prevention and treatment of traveler's diarrhea
2
Fluoroquinolone safety in pediatric patients: a prospective, multicenter, comparative cohort study in France
3
Management of nonsevere pneumonia in military trainees with the urinary antigen test for Streptococcus pneumoniae: an innovative approach to targeted therapy
4
Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001
5
Acute bacterial meningitis in adults: predictors of outcome
6
Human tularemia in France, 2006-2010
7
Bite wounds and infection
8
Drug costs and bacterial susceptibility after implementing a single-fluoroquinolone use policy at a university hospital
9
Impetigo: etiology and therapy
10
Treatment of community-acquired methicillin-resistant Staphylococcus aureus in children
11
Polymicrobial septicemia in the cancer patient
12
Prospective study of the usefulness of sputum Gram stain in the initial approach to community-acquired pneumonia requiring hospitalization
13
Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense
14
Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study of admission and management variation in patients hospitalized with respiratory syncytial viral lower respiratory tract infection
15
Infection in cancer patients. A continuing association
16
Protein binding and its significance in antibacterial therapy
17
Postoperative toxic shock syndrome
18
Comparative antibiotic resistance of diarrheal pathogens from Vietnam and Thailand, 1996-1999
19
Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever
20
Yersinia pestis--etiologic agent of plague
21
Community-acquired bacterial meningitis
22
Prevalence and pathogenicity of Clostridium difficile in hospitalized patients. A French multicenter study
23
Practice guidelines for the management of bacterial meningitis
24
The treatment of dog bite injuries, especially those of the face
25
Does nasal colonization or mupirocin treatment affect recurrence of methicillin-resistant Staphylococcus aureus skin and skin structure infections?
26
Single- versus multiple-dose antimicrobial prophylaxis for major surgery: a systematic review
27
Invasive group A streptococcal infections in Florida
28
Persistent posttraumatic cerebrospinal fluid leakage
29
Fever in immunocompromised patients
30
Survival in neutropenic patients with severe sepsis or septic shock
31
The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients
32
Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota
33
The effect of eradicating helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease
34
Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria
35
Randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus infection
36
Anthrax cases in pregnant and postpartum women: a systematic review
37
Recurrent erysipelas: predisposing factors and costs of prophylaxis
38
Clinical presentation and bacteriologic analysis of infected human bites in patients presenting to emergency departments
39
Pathogen identification of abscesses and cellulitis
40
Methicillin-resistant Staphylococcus aureus disease in three communities
41
The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections
42
Emergency management of dog and cat bite wounds
43
A review of the clinical presentation, laboratory features, antimicrobial therapy and outcome of 77 episodes of pneumococcal meningitis occurring in children and adults
44
The etiology of acute respiratory infections. 3. The role of viruses and bacteria
45
Dog bite wounds and infection: a prospective clinical study
46
High-level gentamicin resistance in Enterococcus faecalis bacteremia
47
The etiology of bacterial cellulitis as determined by fine-needle aspiration
48
Anthrax
49
Office management of minor wounds
50
Clinical utility of blood cultures drawn from indwelling central venous catheters in hospitalized patients with cancer
51
[Clinical guide for the evaluation and treatment of patients with neutropenia and fever]
52
Necrotising fasciitis due to group A streptococci in western Norway: incidence and clinical features
53
Glanders in a military research microbiologist
54
Epidemiology of human plague in the United States, 1900-2012
55
Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure
56
Usefulness of the Streptococcus pneumoniae urinary antigen test in the treatment of community-acquired pneumonia
57
Clostridium difficile-associated diarrhea in HIV-infected patients: epidemiology and risk factors
58
Management of fever in patients with cancer and treatment-induced neutropenia
59
The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida
60
Bacterial pyomyositis in the United States
61
Home management of mild to moderately severe community-acquired pneumonia: a randomised controlled trial
62
Impact of goal-oriented and model-based clinical pharmacokinetic dosing of aminoglycosides on clinical outcome: a cost-effectiveness analysis
63
BTS Guidelines for the Management of Community Acquired Pneumonia in Adults
64
Fungemia with Saccharomycetaceae. Report of four cases and review of the literature
65
Suboptimal aminoglycoside dosing in critically ill patients
66
Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial
67
Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine
68
Emergence of multidrug-resistant Salmonella typhi in rural southern India
69
Streptococcus pyogenes resistance to erythromycin in relation to macrolide consumption in Spain (1986-1997)
70
Bacteraemia in Kenyan children with sickle-cell anaemia: a retrospective cohort and case-control study
71
Correlation of pharmacokinetic indices with therapeutic outcome in patients receiving aminoglycosides
72
A Lactobacillus casei Shirota probiotic drink reduces antibiotic-associated diarrhoea in patients with spinal cord injuries: a randomised controlled trial
73
Impact of rapid detection of viral and atypical bacterial pathogens by real-time polymerase chain reaction for patients with lower respiratory tract infection
74
Recurrent Clostridium difficile disease: epidemiology and clinical characteristics
75
The lack of therapeutic effect of Saccharomyces boulardii in the prevention of antibiotic-related diarrhoea in elderly patients
76
Typhoid fever
77
Typhoid fever in children: experience in King Chulalongkorn Memorial Hospital
78
Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada
79
Group A streptococcal infections in injection drug users in Barcelona, Spain: epidemiologic, clinical, and microbiologic analysis of 3 clusters of cases from 2000 to 2003
80
Lack of effect of Lactobacillus GG on antibiotic-associated diarrhea: a randomized, placebo-controlled trial
81
Complications of bacteriologically confirmed typhoid fever in children
82
Nursing home-acquired pneumonia
83
Amikacin use and therapeutic drug monitoring in adults: do dose regimens and drug exposures affect either outcome or adverse events? A systematic review
84
Prospective derivation and validation of a clinical prediction rule for recurrent Clostridium difficile infection
85
Intake of Lactobacillus plantarum reduces certain gastrointestinal symptoms during treatment with antibiotics
86
Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia
87
Community-acquired pneumonia